Results 131 to 140 of about 118,119 (154)

Durable partial response to pembrolizumab, lenvatinib, and letrozole in a case of recurrent uterine carcinosarcoma with ESR1 gene amplification. [PDF]

Gynecol Oncol Rep
Soiffer JL, Fife AJ, Gadad SS, Laurini JA, Elvin JA, Isani SS, Lin KY.   +6 more
europepmc   +1 more source

Uterine carcinosarcoma with heterologous mesenchymal element: a case report of a rare and aggressive tumor. [PDF]

Oxf Med Case Reports
Asfer S, Hmidan Samsam S, Zakkar R, Jarbouh H.   +3 more
europepmc   +1 more source

HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma. [PDF]

J Gynecol Oncol
Mizoguchi C, Nishikawa T, Yoshida H, Yasuda M, Kato T, Hasegawa K, Yonemori K.   +6 more
europepmc   +1 more source

Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids. [PDF]

Front Oncol
Dahl MJ, Lofgren KA, Haugen C, Harmon GE, Hughes SP, Cowden Dahl KD.   +5 more
europepmc   +1 more source

Clinical and multiparametric MRI features for differentiating uterine carcinosarcoma from endometrioid adenocarcinoma. [PDF]

BMC Med Imaging
Chen X, Guo Q, Chen X, Zheng W, Kang Y, Cao D.   +5 more
europepmc   +1 more source

Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2009
Objective: The aims of this study were to determine the prognostic factors, survival outcomes and response to adjuvant therapy in women with uterine carcinosarcoma treated in a single institution.
Khadra Galaal
exaly   +2 more sources

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma [PDF]

Gynecologic Oncology, 2015
To evaluate the use of adjuvant therapy after primary surgery for stage I–III uterine carcinosarcoma (CS)
Stephanie Ricci, Laura J. Havrilesky, Rachel Isaksson Vogel   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival

Cancers, 2023
Ronalds Macuks, Yusuf Yildirim
exaly  

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

Annals of Oncology, 2016
Kiyoshi Yoshino, Koji Matsuo, Iwasaki Kenta   +2 more
exaly  

Integrated Molecular Characterization of Uterine Carcinosarcoma

Cancer Cell, 2017
Vonn Walter, David Neil Hayes, Rameen Beroukhim   +2 more
exaly